Warwick Smith, Director General of the British Generic Manufacturers Association (BGMA), said: “We welcome the fact that the Government is working with industry to secure the supply of medicines to patients in the case of a no-deal Brexit. Our members have cooperated with the Government’s request for holding additional stocks and providing data to allow them to assess the risk to the supply of medicines, and to work with us on putting in place mitigating measures.
“However, whilst the outcome of Brexit clearly remains uncertain, it is now the time to accelerate this work and putting mitigating measures in place takes time. Therefore, while an update from the Secretary of State is helpful, it contains less detailed information than leaks from other Government Departments. It is vitally important that the Government shares with us and others all their current information so that we can plan accordingly.”